Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: +$21.7K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 6 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 11 most recent Form 4 transactions.
| Mar 19 | ANTX | AN2 Therapeutics, Inc. | AGRANT◆ | 23,742 | — | — | — | Open the original filing on SEC.gov |
| Mar 19 | ANTX | AN2 Therapeutics, Inc. | DTOISS◆ | 10,362 | — | — | — | Open the original filing on SEC.gov |
| Mar 19 | ANTX | AN2 Therapeutics, Inc. | AGRANT◆ | 10,362 | — | — | — | Open the original filing on SEC.gov |
| Mar 19 | ANTX | AN2 Therapeutics, Inc. | DTOISS◆ | 11,463 | — | — | — | Open the original filing on SEC.gov |
| Mar 19 | ANTX | AN2 Therapeutics, Inc. | AGRANT◆ | 11,463 | — | — | — | Open the original filing on SEC.gov |
| Feb 20 | ANTX | AN2 Therapeutics, Inc. | AGRANT◆ | 20,400 | — | — | — | Open the original filing on SEC.gov |
| Sep 9, 2025 | VTGN | Vistagen Therapeutics,… | AGRANT◆ | 17,600 | — | — | — | Open the original filing on SEC.gov |
| May 28, 2025 | ANTX | AN2 Therapeutics, Inc. | PBUY | 8,610 | $1.18 | $10.1K | — | Open the original filing on SEC.gov |
| May 22, 2025 | ANTX | AN2 Therapeutics, Inc. | AGRANT◆ | 19,111 | — | — | — | Open the original filing on SEC.gov |